Cargando…

Neurological manifestations in patients with antiphospholipid syndrome

BACKGROUND: Anti-phospholipids syndrome (APS) is considered a non inflammatory auto-immune disease with a significant thrombophilic risk with varied clinical manifestations. The purpose of the current study was to investigate the frequency of thrombotic and non-thrombotic events in patients with APS...

Descripción completa

Detalles Bibliográficos
Autores principales:	Etemadifar, Masoud, Dehghani, Leila, Tahani, Soheil, Toghianifar, Nafiseh, Rahaimi, Marzieh, Eskandari, Nahid
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Tehran University of Medical Sciences 2013
Materias:	Short Communication
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3829301/ https://www.ncbi.nlm.nih.gov/pubmed/24250929

Ejemplares similares

Neurologic Manifestations of the Antiphospholipid Syndrome — an Update
por: Leal Rato, Miguel, et al.
Publicado: (2021)

Can Vitamin D Suppress Endothelial Cells Apoptosis in Multiple Sclerosis Patients?
por: Dehghani, Leila, et al.
Publicado: (2013)

Neurological and Neuropsychiatric Manifestations of Antiphospholipid-Antibody Syndrome (APS)
por: Asif, Saba, et al.
Publicado: (2022)

Circadian rhythm sleep disorders in patients with multiple sclerosis and its association with fatigue: A case-control study
por: Najafi, Mohammad Reza, et al.
Publicado: (2013)

Recurrent Non-stroke Central Neurologic Manifestations in Primary Antiphospholipid Syndrome
por: You, Hanxiao, et al.
Publicado: (2022)

Revisiting the Molecular Mechanism of Neurological Manifestations in Antiphospholipid Syndrome: Beyond Vascular Damage
por: Carecchio, M., et al.
Publicado: (2014)

Evaluation of the circulating CD34(+), CD309(+), and endothelial progenitor cells in patients with first attack of optic neuritis
por: Etemadifar, Masoud, et al.
Publicado: (2015)

Unusual manifestations of the antiphospholipid syndrome
por: Asherson, Ronald A., et al.
Publicado: (2003)

Rapid exacerbation of multiple sclerosis following the initiation of interferon-β: report of nine cases
por: Etemadifar, Masoud, et al.
Publicado: (2011)

Is it necessary to perform connective tissue disorders laboratory tests when a patient experiences the first demyelinating attack?
por: Etemadifar, Masoud, et al.
Publicado: (2013)

Nonarteritic anterior ischemic optic neuropathy as the presenting manifestation of primary antiphospholipid syndrome
por: Tugcu, Betul, et al.
Publicado: (2014)

Interleukin 18 Polymorphisms and its serum level in Patients with Multiple Sclerosis
por: Jahanbani-Ardakani, Hamidreza, et al.
Publicado: (2019)

IgA Antiphospholipid Antibodies in Antiphospholipid Syndrome and Systemic Lupus Erythematosus
por: Reshetnyak, Tatiana, et al.
Publicado: (2022)

Non-Criteria Manifestations of Juvenile Antiphospholipid Syndrome
por: Miyamae, Takako, et al.
Publicado: (2021)

Gastrointestinal symptoms as the first manifestation of antiphospholipid syndrome
por: Zou, Xiaojuan, et al.
Publicado: (2021)

Radiographic and clinical neurologic manifestations of COVID-19 related hypoxemia
por: Radnis, Caitlin, et al.
Publicado: (2020)

Ocular manifestations of Rickettsiosis: 2. Retinal involvement and treatment
por: Matri, Leila El
Publicado: (2009)

Fatigue, depression, and physical impairment in multiple sclerosis
por: Azimian, Mojtaba, et al.
Publicado: (2014)

Ocular manifestations of the antineutrophil cytoplasmic antibody and antiphospholipid syndromes
por: Khan, Sujoy
Publicado: (2013)

Neuropsychiatric Manifestations of Antiphospholipid Syndrome—A Narrative Review
por: Man, Yik Long, et al.
Publicado: (2022)

Point of care testing to monitor INR control in patients with antiphospholipid syndrome
por: Masucci, Michael, et al.
Publicado: (2022)

Outcome of COVID-19 infection in multiple sclerosis patients receiving disease-modifying therapies
por: Etemadifar, Masoud, et al.
Publicado: (2021)

Antiphospholipid antibodies: Paradigm in transition
por: Horstman, Lawrence L, et al.
Publicado: (2009)

Pulmonary manifestations of systemic lupus erythematosus patients with and without antiphospholipid syndrome
por: Hamdani, Muhammad Afzal, et al.
Publicado: (2015)

Association between sleep duration and metabolic syndrome in a population-based study: Isfahan Healthy Heart Program
por: Najafian, Jamshid, et al.
Publicado: (2011)

Evaluation of the prevalence of bovine leukemia virus DNA in peripheral blood mononuclear cells of multiple sclerosis patients
por: Jeda, Ali Salimi, et al.
Publicado: (2023)

Disseminated intracardiac thrombosis: a rare manifestation of antiphospholipid syndrome
por: Abanador-Kamper, Nadine, et al.
Publicado: (2012)

Mechanisms of Endothelial Dysfunction in Antiphospholipid Syndrome: Association With Clinical Manifestations
por: Velásquez, Manuela, et al.
Publicado: (2018)

Cardiac Manifestations of Antiphospholipid Syndrome With Focus on Its Primary Form
por: Kolitz, Tamara, et al.
Publicado: (2019)

Current concepts in the diagnosis and management of antiphospholipid syndrome and ocular manifestations
por: Uludag, Gunay, et al.
Publicado: (2021)

Organophosphate intermediate syndrome with neurological complications of extrapyramidal symptoms in clinical practice
por: Detweiler, Mark B.
Publicado: (2014)

Lavender protects H9c2 cardiomyocytes against oxygen-glucose deprivation (OGD)-induced injury via targeting the JAK2/STAT3 pathway
por: Askarian-Amiri, Shaghayegh, et al.
Publicado: (2022)

Sudden Cardiac Arrest as the First Manifestation in a Patient with Catastrophic Antiphospholipid Syndrome
por: Sahashi, Yuki, et al.
Publicado: (2020)

Serum Calprotectin as a Potential Predictor of Microvascular Manifestations in Patients with Antiphospholipid Syndrome
por: Zhao, Yuan, et al.
Publicado: (2023)

Primary adrenal insufficiency in case of antiphospholipid syndrome
por: Sanyal, Debmalya, et al.
Publicado: (2013)

Antiphospholipid antibodies and neurological manifestations in acute COVID-19: A single-centre cross-sectional study
por: Benjamin, Laura A., et al.
Publicado: (2021)

Rivaroxaban – a safe therapeutic option in patients with antiphospholipid syndrome? Our experience in 23 cases
por: Haładyj, Ewa, et al.
Publicado: (2016)

Ocular disorders as the prevailing manifestations of antiphospholipid syndrome: a case series
por: Tsironi, Evangelia, et al.
Publicado: (2009)

Nasal Skin Necrosis: A Very Rare Manifestation of Antiphospholipid Syndrome
por: Ourique, Carolina, et al.
Publicado: (2017)

Evaluation of a gene signature related to thrombotic manifestations in antiphospholipid syndrome
por: Jacintho, Bruna Cardoso, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_ch0uh5sj4qr7guuikhrekuf62l